
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
[ Mon, May 08th 2023 ]: WOPRAI
David Amsellem Maintained (AMRX) at Buy with Decreased Target to $3 on, May 8th, 2023


🞛 This publication is a summary or evaluation of another publication
David Amsellem of Piper Sandler, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Buy with Decreased Target from $5 to $3 on, May 8th, 2023.
David has made no other calls on AMRX in the last 4 months.
There are 4 other peers that have a rating on AMRX. Out of the 4 peers that are also analyzing AMRX, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $4 on, Friday, March 3rd, 2023
These are the ratings of the 3 analyists that currently disagree with David
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $4 on, Wednesday, March 29th, 2023
- Balaji Prasad of "Barclays" Maintained at Buy with Decreased Target to $4 on, Friday, March 10th, 2023
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $3 on, Friday, March 3rd, 2023